Olorutec Eye Drops 0.2% (Olopatadine Hydrochloride), Olorutec Eye Drops 0.2% (Olopatadine Hydrochloride) (single-use)

Adult eye dose

1 drop per dose, instilled once daily.

This medication should not be used by patients who have allergic reactions to the active ingredient or components. During use, neurological symptoms such as headaches, altered taste, and dizziness may occur. Symptoms such as punctate keratitis, keratitis, eye pain, dryness, swelling, itching, discharge, redness, and discomfort are commonly reported. Additionally, glare, blurred vision, and eyelid redness may occur rarely. Nasal dryness or rhinitis symptoms may appear rarely, and dry mouth or contact dermatitis may also be reported rarely. Fatigue may occur. Similar symptoms to colds or pharyngitis may occur in about 10% of patients. Symptoms such as weakness, lower back pain, flu-like symptoms, frequent coughing, infections, nausea, and sinusitis have been reported in some patients. This medication contains phosphates and can rarely cause corneal calcification in patients with severe corneal damage. Caution is required when wearing contact lenses, and particularly for soft lens wearers, lenses should not be worn for at least 15 minutes after using this medication. This medication is an eye drop used only for the eyes and is not for oral or intravenous administration. Care should be taken to prevent the tip of the container from touching the eye, and the cap must be closed tightly after use. Vision may be temporarily blurred after using this medication, so driving or operating machinery should be avoided until vision clears. If pregnant or breastfeeding, careful use should be considered based on potential effects on the fetus or baby. It can also be used by children over 3 years old, and the elderly can use it safely. In case of overdose, proper observation and management are required. If using with other eye drops, a minimum interval of 5 minutes should be maintained, and single-use products should be used immediately after opening, and any remaining medication should be discarded. This medication is known to have a low risk of carcinogenic or mutagenic effects and minimal impact on reproductive ability.

Mild side effects

Headaches, altered taste, dizziness, punctate keratitis, keratitis, eye pain, dry eyes, eyelid swelling, eye itching, eye discharge, eye redness, keratinization of the eyelid margin, eye discomfort, glare, blurred vision, eyelid redness, nasal dryness, rhinitis, dry mouth, contact dermatitis, fatigue, symptoms similar to colds and pharyngitis, weakness, lower back pain, flu-like symptoms, frequent coughing, infections, nausea, sinusitis, increased tear secretion

The storage method differs between multi-dose and single-use medications. Multi-dose medications should be stored in a sealed container that blocks light and prevents air from entering, maintaining a temperature between 4°C and 25°C. Single-use medications should be stored in a sealed container that prevents air from entering, maintaining a temperature between 2°C and 25°C. Storing in this manner helps to maintain the effectiveness of the medication over time.

Appearance

Multi-dose: A colorless to pale yellow liquid in an opaque white plastic container for eye drops. Single-use: A colorless to pale yellow liquid in a colorless transparent plastic container for eye drops.

Package unit

Multi-dose - 3 milliliters/bottle, Single-use - 30 pieces/box [(0.3 mL/tube x 30 pieces)]